{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T17:08:30Z","timestamp":1777828110087,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81804007"],"award-info":[{"award-number":["81804007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.phymed.2025.156497","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T11:25:16Z","timestamp":1740396316000},"page":"156497","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Hua Zheng San Ji Fang suppresses liver cancer progression by inhibiting TYRO3 expression via the ERK signaling pathway"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5965-4416","authenticated-orcid":false,"given":"Zhuang","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodan","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boyang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2025.156497_bib0001","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejmech.2016.01.012","article-title":"PI3K\/Akt\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives","volume":"109","author":"Asati","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phymed.2025.156497_bib0002","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer-derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2025.156497_bib0003","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","article-title":"Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma","volume":"23","author":"Chan","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2025.156497_bib0004","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1038\/onc.2016.120","article-title":"Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer","volume":"35","author":"Chien","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2025.156497_bib0005","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41571-023-00813-7","article-title":"TAM family kinases as therapeutic targets at the interface of cancer and immunity","volume":"20","author":"DeRyckere","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phymed.2025.156497_bib0006","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3892\/ijo.2015.3244","article-title":"Overexpression of Tyro3 and its implications on hepatocellular carcinoma progression","volume":"48","author":"Duan","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.phymed.2025.156497_bib0007","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41416-019-0397-6","article-title":"TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer","volume":"120","author":"Dufour","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phymed.2025.156497_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102221","article-title":"Cabozantinib: an evolving therapy for hepatocellular carcinoma","volume":"98","author":"El-Khoueiry","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phymed.2025.156497_bib0009","doi-asserted-by":"crossref","first-page":"e34396","DOI":"10.1097\/MD.0000000000034396","article-title":"Exploring the inhibition mechanism of interleukin-1-beta in gouty arthritis by polygonum cuspidatum using network pharmacology and molecular docking: a review","volume":"102","author":"Ge","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.phymed.2025.156497_bib0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/1061186X.2024.2309661","article-title":"Advances in herbal polysaccharides-based nano-drug delivery systems for cancer immunotherapy","volume":"32","author":"Han","year":"2024","journal-title":"J. Drug Target."},{"key":"10.1016\/j.phymed.2025.156497_bib0011","first-page":"13","article-title":"Intrinsic and extrinsic control of hepatocellular carcinoma by TAM receptors","author":"Hedrich","year":"2021","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.phymed.2025.156497_bib0012","doi-asserted-by":"crossref","first-page":"eade3422","DOI":"10.1126\/sciadv.ade3422","article-title":"Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis","volume":"9","author":"Hsu","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.phymed.2025.156497_bib0013","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1535370219828195","article-title":"TYRO3: a potential therapeutic target in cancer","volume":"244","author":"Hsu","year":"2019","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.phymed.2025.156497_bib0014","first-page":"131","article-title":"TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis","author":"Jiang","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phymed.2025.156497_bib0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/hep.29478","article-title":"A microRNA-7\/growth arrest specific 6\/TYRO3 axis regulates the growth and invasiveness of sorafenib-resistant cells in human hepatocellular carcinoma","volume":"67","author":"Kabir","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2025.156497_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.730241","article-title":"G-749 promotes receptor tyrosine kinase TYRO3 degradation and induces apoptosis in both colon cancer cell lines and xenograft mouse models","volume":"12","author":"Kim","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2025.156497_bib0017","doi-asserted-by":"crossref","first-page":"8255","DOI":"10.1093\/nar\/gkaa615","article-title":"Upregulation of BCL-2 by acridone derivative through gene promoter i-motif for alleviating liver damage of NAFLD\/NASH","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.phymed.2025.156497_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111381","article-title":"Traditional Chinese medicine and lung cancer\u2013from theory to practice","volume":"137","author":"Li","year":"2021","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2025.156497_bib0019","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.phymed.2025.156497_bib0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-023-00846-8","article-title":"Therapeutic targeting of the functionally elusive TAM receptor family","volume":"23","author":"Miao","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phymed.2025.156497_bib0021","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-019-1022-2","article-title":"Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment","volume":"18","author":"Myers","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2025.156497_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113688","article-title":"Pharmacology, phytochemistry, and traditional uses of Scrophularia ningpoensis Hemsl","volume":"269","author":"Ren","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2025.156497_bib0023","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev-immunol-032414-112103","article-title":"TAM receptor signaling in immune homeostasis","volume":"33","author":"Rothlin","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.phymed.2025.156497_bib0024","first-page":"3035","article-title":"TYRO3 promotes tumorigenesis and drug resistance in colorectal cancer by enhancing the epithelial-mesenchymal transition process","volume":"15","author":"Shao","year":"2023","journal-title":"Aging (Albany. NY)"},{"key":"10.1016\/j.phymed.2025.156497_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107893","article-title":"Resolving inflammation by TAM receptor activation","volume":"227","author":"Vago","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phymed.2025.156497_bib0026","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3835(01)00828-X","article-title":"Regulation of bcl-2 family molecules and activation of caspase cascade involved in gypenosides-induced apoptosis in human hepatoma cells","volume":"183","author":"Wang","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phymed.2025.156497_bib0027","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-018-0769-1","article-title":"Targeting Gas6\/TAM in cancer cells and tumor microenvironment","volume":"17","author":"Wu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2025.156497_bib0028","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phymed.2025.156497_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155135","article-title":"Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2\/HO-1\/GPX4 axis","volume":"122","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2025.156497_bib0030","article-title":"Research status and molecular mechanism of the traditional Chinese medicine and antitumor therapy combined strategy based on tumor microenvironment","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2025.156497_bib0031","article-title":"Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Immunol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325001382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325001382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T13:21:25Z","timestamp":1774963285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325001382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":31,"alternative-id":["S0944711325001382"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156497","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hua Zheng San Ji Fang suppresses liver cancer progression by inhibiting TYRO3 expression via the ERK signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.156497","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156497"}}